Board of Directors

Gisela Sitbon (1958), Chairman

Board member since 2012,
Chairman since 2014

Education and training: Doctorate in medical sciences from the Karolinska Institute in Solna
Main experience: Twenty-five years’
experience in the life science industry, of which just over ten years in senior positions (including CEO) at Professional Genetics
Laboratory AB and five years as head of
section at Karo Bio AB. Business coach in the life science sector at STING AB and
responsible for business development for growth companies at her own company ZENZ AB.
Other board appointments: Board member and chairperson of Beactica AB and board member of Sitbon Bioscience Partner Zenz AB and Pharmacolog in Uppsala AB (publ.)

Holds 5,000 shares through the company Sitbon Bioscience Partner Zenz AB.

peter-e_hemsidaPeter von Ehrenheim (1955)

Board member since 2016

Education and training: Master of Science in Mechanical Engineering from Royal
Institute of Technology (KTH), Stockholm.
Main experience: Head of the separation
division at Amersham and GE Healthcare between 2000 and 2006, and CEO of GE Healthcare Life Sciences 2006 to 2011.
Other board appointments: Chairman of
Biolin Scientific AB, Boule Diagnostics AB, VBN Components AB and Robustus Wear Components AB and board member of
Biotage AB and Meda AB.

Holds 1,000 shares.

 

Hans Lennernäs (1960)

Board member since 2014

Education and training: Doctorate in
pharmacy from Uppsala University
Main experience: Professor of Biopharmacy at the Department of Pharmacy, Uppsala
University. Co-founder of, among others,
DuoCort Pharma AB and LIDDS AB.
Other board appointments: Board member of Hans Lennernäs Biomedical AB, Recipharm Pharmaceutical Development AB and Empros Pharma AB

Holds 6,000 shares through the company Hans Lennernäs Biomedical AB.

 

Mårten Steen (1976)

Board member since 2015

Education and training: LL.B. from Uppsala
University
Main experience: Lawyer and co-owner of
Advokatfirman Lindahl, with particular
experience in corporate law, business transfers, private equity, stock market law and commercial contract law. He is a member of Lindahl’s competency group for corporate finance and works with clients in a variety of sectors, even if most of them are active in the field of life science.
Other board appointments: Board member and co-owner of Advokatfirman Lindahl in Uppsala AB, board member of Villa Anna AB and Kyrkans Försäkrings AB

Holds no shares in Nanologica.

Lena Torlegård (1963)

Board member since 2014

Education and training: B.Sc in business
administration from the Stockholm School of Economics
Main experience: Over 15 years’ experience as a communications consultant, for
companies in the life science sector as well. She works primarily with financial communications and corporate communications but also with crisis management and trademark issues. Senior consultant at Springtime AB in Stockholm.
Other board appointments: Board member of Lytix Biopharma AS

Holds 2,500 shares.

 

Paula Zeilon (1962)

Board member since 2016

Education and training: Master of Science in
Chemical Engineering from the Faculty of Engineering (LTH) at Lund University.
Graduate Engineer Program, Stockholm School of Economics.
Main experience: Thirty years’ experience from the life science industry, of which 14 years within chromatography at Amersham Biosciences, in senior positions within
product development and marketing. Paula is one of the founders of the consulting firm Conlega and has since 2000 been working with numerous life science companies with business development and interim management, among others as CEO at Life
Science Foresight Institute, CEO at Alligator Bioscience, Director Marketing at Dako A/S, Director Marketing at Biotage and Director Business Development at Amersham.
Other board appointments: Board member of BioGaia AB.

Holds no shares in Nanologica.